Insider Transactions in Q4 2024 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
13,196
-4.78%
|
$356,292
$27.16 P/Share
|
|
Dec 16
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,604
-2.68%
|
$205,308
$27.33 P/Share
|
|
Nov 26
2024
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
216
-0.36%
|
$5,832
$27.2 P/Share
|
|
Nov 26
2024
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
349
-0.32%
|
$9,423
$27.2 P/Share
|
|
Nov 26
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
523
-0.18%
|
$14,121
$27.2 P/Share
|
|
Nov 26
2024
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
581
-0.47%
|
$15,687
$27.2 P/Share
|
|
Nov 26
2024
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
252
-0.16%
|
$6,804
$27.2 P/Share
|
|
Nov 18
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
17,604
-5.83%
|
$352,080
$20.05 P/Share
|
|
Nov 15
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.89%
|
$525,000
$21.17 P/Share
|
|
Nov 15
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.97%
|
$20,000
$2.06 P/Share
|
|
Nov 12
2024
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
147
-0.12%
|
$3,822
$26.19 P/Share
|
|
Nov 12
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
123
-0.04%
|
$3,198
$26.34 P/Share
|
|
Nov 12
2024
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
66
-0.04%
|
$1,716
$26.34 P/Share
|
|
Nov 12
2024
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
91
-0.08%
|
$2,366
$26.34 P/Share
|
|
Oct 30
2024
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
894
-0.72%
|
$20,562
$23.15 P/Share
|
|
Oct 30
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
547
-0.17%
|
$12,581
$23.15 P/Share
|
|
Oct 30
2024
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
277
-0.18%
|
$6,371
$23.15 P/Share
|
|
Oct 30
2024
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
311
-0.29%
|
$7,153
$23.15 P/Share
|
|
Oct 30
2024
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
203
-0.33%
|
$4,669
$23.15 P/Share
|
|
Oct 16
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.05%
|
$230,000
$23.17 P/Share
|
|
Oct 16
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.96%
|
$20,000
$2.06 P/Share
|
|
Oct 15
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-3.05%
|
$230,000
$23.28 P/Share
|
|
Oct 15
2024
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.96%
|
$20,000
$2.06 P/Share
|